Follow
Nadine Taleb
Title
Cited by
Cited by
Year
Rfx6 directs islet formation and insulin production in mice and humans
SB Smith, HQ Qu, N Taleb, NY Kishimoto, DW Scheel, Y Lu, AM Patch, ...
Nature 463 (7282), 775-780, 2010
3932010
Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover …
N Taleb, A Emami, C Suppere, V Messier, L Legault, M Ladouceur, ...
Diabetologia 59, 2561-2571, 2016
1332016
The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes
V Gingras, N Taleb, A Roy‐Fleming, L Legault, R Rabasa‐Lhoret
Diabetes, Obesity and Metabolism 20 (2), 245-256, 2018
1092018
Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at rest and during exercise
N Taleb, A Emami, C Suppere, V Messier, L Legault, JL Chiasson, ...
Diabetes technology & therapeutics 18 (9), 561-567, 2016
762016
Glucagon in artificial pancreas systems: potential benefits and safety profile of future chronic use
N Taleb, A Haidar, V Messier, V Gingras, L Legault, R Rabasa‐Lhoret
Diabetes, Obesity and Metabolism 19 (1), 13-23, 2017
612017
The benefits and limits of technological advances in glucose management around physical activity in patients type 1 diabetes
S Tagougui, N Taleb, R Rabasa-Lhoret
Frontiers in endocrinology 9, 818, 2019
552019
Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized …
A Roy-Fleming, N Taleb, V Messier, C Suppère, C Cameli, S Elbekri, ...
Diabetes & metabolism 45 (3), 294-300, 2019
422019
Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation
B Elisha, M Azar, N Taleb, S Bernard, G Iacobellis, R Rabasa-Lhoret
Hormone and metabolic research 48 (01), 42-47, 2016
422016
Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives
S Tagougui, N Taleb, J Molvau, É Nguyen, M Raffray, R Rabasa-Lhoret
Journal of diabetes science and technology 13 (6), 1077-1090, 2019
382019
Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon
N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah
Annals of Saudi Medicine 28 (6), 420-425, 2008
322008
Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients
HI Salti, MP Nasrallah, NM Taleb, M Merheb, S Haddad, J El-Annan, ...
Canadian Journal of Ophthalmology 44 (3), 308-313, 2009
292009
The promising future of insulin therapy in diabetes mellitus
R Cheng, N Taleb, M Stainforth-Dubois, R Rabasa-Lhoret
American Journal of Physiology-Endocrinology and Metabolism 320 (5), E886-E890, 2021
282021
A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes …
S Tagougui, N Taleb, L Legault, C Suppère, V Messier, I Boukabous, ...
Diabetologia 63, 2282-2291, 2020
272020
Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: results of an online survey
N Taleb, V Messier, S Ott-Braschi, JL Ardilouze, R Rabasa-Lhoret
Diabetes Research and Clinical Practice 144, 42-50, 2018
252018
Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum over the course of moderate intensity aerobic exercise in type 1 diabetes
S Larose, R Rabasa-Lhoret, A Roy-Fleming, C Suppère, S Tagougui, ...
Diabetes technology & therapeutics 21 (6), 364-369, 2019
222019
Self-reported severe and nonsevere hypoglycemia in type 1 diabetes: population surveillance through the BETTER patient engagement registry: development and baseline characteristics
AS Brazeau, V Messier, MK Talbo, C Gagnon, N Taleb, I Fortier, Z Wu, ...
Canadian Journal of Diabetes 46 (8), 813-821, 2022
202022
Duration of catheter use in patients with diabetes using continuous subcutaneous insulin infusion: a review
L Bonato, N Taleb, V Gingras, V Messier, F Gobeil, J Ménard, ...
Diabetes technology & therapeutics 20 (7), 506-515, 2018
192018
Vascular complications of diabetes in Lebanon: experience at the American University of Beirut
N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah
The British Journal of Diabetes & Vascular Disease 8 (2), 80-83, 2008
192008
Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes?
N Taleb, R Rabasa-Lhoret
Diabetologia 59, 1632-1635, 2016
152016
Minimizing the risk of exercise-induced glucose fluctuations in people living with type 1 diabetes using continuous subcutaneous insulin infusion: an overview of strategies
J Molveau, R Rabasa-Lhoret, N Taleb, E Heyman, É Myette-Côté, ...
Canadian journal of diabetes 45 (7), 666-676, 2021
132021
The system can't perform the operation now. Try again later.
Articles 1–20